The latest -Cancer Therapeutics Markets -Report By Aarkstore

FOR IMMEDIATE RELEASE
(Free-Press-Release.com) January 23, 2012 -- Cancer Therapeutics Markets
http://www.emarketreports.com/reports/Cancer-Therapeutics-Markets-180674.html

Cancer is the second leading cause of death by disease in the United States, exceeded only by heart disease. Traditionally cancer has been treated with surgery, chemotherapy, hormones and radiation therapy, alone or in combination. Emerging technologies include photodynamic therapy, gene therapy, biological therapy (immunotherapy) and angiogenesis inhibitors. Pharmaceutical and biotechnology companies are investing billions of dollars to search out and develop weapons for the arsenal in the war against cancer. This TriMark Publications report provides an overview of the global market for cancer therapeutics. The examination focuses on the efforts of biotechnology companies and pharmaceutical firms to incorporate new technologies for developing anti-cancer drugs into their corporate strategies. This study examines cancer therapeutic products now on the market, as well as those currently under development that might be commercialized in the near future. Additionally, the report profiles a number of firms that are actively involved in marketing and developing of products to be used in the treatment of cancer--both large multinational corporations. The analysis also provides an overview of the disease and data on cancers by site or type. It provides incidence and mortality data for different types of the disease. In addition, the report provides a summary of each of the therapies that are being used to treat cancer.

Table of Contents :
1. Overview 5
1.1 Introduction 5
1.2 Goals and Objectives 6
1.3 Study, Scope and Format 6
1.4 Methodology 6
1.5 Summary of Major Findings 8
2. Introduction to the Cancer Therapeutic Market 10
3. Cancer Therapeutics Market Overview 18
3.1 Cancer Therapeutics in the Pharmaceutical and Biotech Industry 18
3.2 Business Analysis of the Cancer Market 25

INDEX OF TABLES

Table 2.1: The 646 Medicines in Development for Cancer, 2006 10

Table 2.2: Drug Approvals for Cancer Indications, 1996-2007 11
Table 3.1: Opportunities for Molecular-Targeting Therapeutics for Cancer 20
Table 3.2: Top U.S. Biotechnology Companies by Market Capitalization 21
Table 3.3: Top Pharmaceutical Companies by Market Capitalization 21
Table 3.4: Clinical Development for some of Hoffman-La Roche Products 22
Table 3.5: Global Pharmaceutical Industry R&D Spending, 1995-2006 28
Related Reports:
Cancer Vaccines Markets
Cardiac Marker Diagnostic Testing Markets
Cardiac Rhythm Management Devices World Markets
Cell Therapy Markets

Cell-Based Assays for Drug Discovery
From: Aarkstore Enterprise
Contact: Marketing Team
Mob.No.918149852585/919272852585
Email: enquiry@aarkstore.com
URL: http://www.aarkstore.com/
http://in.linkedin.com/in/aarkstore
http://www.facebook.com/aarkstore

aarkstore     diagnostic     marketing team     world markets